GeneDx price target raised to $135 from $118 at TD Cowen
TD Cowen raised the firm’s price target on GeneDx (WGS) to $135 from $118 and keeps a Buy rating on the shares. The firm said they provided ...
GeneDx price target raised to $114 from $95 at Craig-Hallum
Craig-Hallum raised the firm’s price target on GeneDx (WGS) to $114 from $95 and keeps a Buy rating on the shares. Q4 results demonstrate the ...
ABC News9d
GeneDx CEO wants genetic testing for every newborn
GeneDx is targeting a big market for its genetic testing: every newborn baby GeneDx has a big market in mind for its genetic testing: every newborn baby. The 24-year-old-company wants to make the ...
ETF Daily News3d
GeneDx (WGS) Projected to Post Earnings on Tuesday
GeneDx stock opened at $76.35 on Friday. The firm has a market cap of $2.10 billion, a PE ratio of -24.55 and a beta of 2.01. The company has a debt-to-equity ratio of 0.25, a quick ratio of 2.27 ...
Business Wire6d
GeneDx Announces ultraRapid Whole Genome Sequencing, Delivering Actionable Results in as soon as 48 Hours to Inform Care for Critically Ill NICU and PICU Patients
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced ultraRapid Whole Genome Sequencing, offering ...
Business Wire9d
GeneDx Integrates with Epic, Enabling Broad Adoption of Genome and Exome Sequencing for Health Systems to Inform Patient Diagnosis and Accelerate Treatment
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, announced today its launch on Aura, Epic’s specialty ...
Newsday9d
GeneDx CEO wants genetic testing for every newborn
GeneDx has a big market in mind for its genetic testing: every newborn baby. The 24-year-old-company wants to make the testing common at birth. The goal: Identify potential diseases or conditions ...